Balyasny Asset Management LLC Adma Biologics, Inc. Put Options Transaction History
Balyasny Asset Management LLC
- $54.8 Billion
- Q1 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ADMA
# of Institutions
224Shares Held
174MCall Options Held
85.5KPut Options Held
12.8K-
Black Rock Inc. New York, NY18.2MShares$212 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$148 Million0.0% of portfolio
-
State Street Corp Boston, MA10.6MShares$123 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL10.5MShares$122 Million0.02% of portfolio
-
Invesco Ltd. Atlanta, GA7.8MShares$90.8 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...